Group captives are among the fastest-growing segments of the captive insurance market, expanding options and creating a greater need for advisors to help clients evaluate quality and risk.

With many Americans living with one or more chronic conditions, advanced primary care can help better manage these patient ...

The survey also noted that 34% of firms require lifestyle or clinical support programs in order for employees to receive GLP-1 agonists for weight loss.

Cigna achieved typical stop-loss customer retention levels, in spite of the price increases, and, in the third quarter, the business "performed in line with expectations," Evanko said. Cigna hopes to ...

Although the ACA included some changes to employer-sponsored health insurance as well, particularly for plans sold to small companies, the changes were more minimal for larger employers, which ...

Being a millionaire apparently is not what it used to be. Only slightly more than one-third of the wealthiest Americans actually consider themselves wealthy, nearly half say their financial planning ...

Dr. George Tidmarsh, director of the agency’s Center for Drug Evaluation and Research, had been placed on leave last Friday pending an investigation by the HHS Office of Inspector General.

Bankruptcy filings show that Trinity owes more than $300 million and that the list of creditors includes 60,000 former cost-sharing ministry members, according to a complaint filed by the liquidating ...

Employers cannot afford complacency or the false comfort of rate caps and blanket No New Laser provisions that disguise risk rather than manage it.

Executives at Aon and Gallagher say that the U.S. labor market still looks strong, but that big increases in U.S. health coverage costs are definitely getting employers' attention.

James Gelfand, the president of ERIC, said draft guidance the U.S. Food and Drug Administration posted Wednesday could create new competition for "biologic" medications.

Medical costs are up 6%,, drug costs are up 10%, and there are "no signs this trend will slow," Brown & Brown's CEO says.